GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 112 Name of the Statue Nature of Dues Forum where dispute is pending Period to which the amount relates# Amount involved Amount Unpaid ( ` in Lakhs) ( ` in Lakhs) Sales Tax and Laws as per statues applicable in various states Sales Tax and VAT Appellate Authority - up to Commissioners / Revisional authorities Level 1983-84, 1987-88 to 1994-95, 1996-97 to 2006-2017 23,85.66 18,90.90 Appellate Authority - Tribunal 1998-99 to 1999-00, 2001- 02 to 2002-03, 2005-06 to 2012-13 66,22.75 61,55.75 High Court 1990-91, 1999-2000, 2001-02 to 2005-06 2,76.06 2,30.58 Supreme Court 1993-94, 1994-95 42.14 42.14 Sub-total 93,26.61 83,19.37 TOTAL 468,42.13 287,16.64 # generally, the year refers to financial year i.e. April to March (viii) There were no transactions relating to previously unrecorded income that were surrendered or disclosed as income in the tax assessments under the Income Tax Act, 1961 (43 of 1961) during the year. (ix) (a) The Company has not taken any loans or other borrowings from any lender. Hence reporting under clause (ix)(a) of the Order is not applicable to the Company. (b) The Company has not been declared wilful defaulter by any bank or financial institution or government or any government authority. (c) The Company has not taken any term loan during the year and there are no unutilised term loans at the beginning of the year and hence, reporting under clause (ix)(c) of the Order is not applicable. (d) On an overall examination of the financial statements of the Company, funds raised on short-term basis have, prima facie, not been used during the year for long-term purposes by the Company. (e) On an overall examination of the financial statements of the Company, the Company has not taken any funds from any entity or person on account of or to meet the obligations of its subsidiary. The Company did not have any associate or joint venture during the year. (f) The Company has not raised any loans during the year and hence reporting on clause (ix)(f) of the Order is not applicable. (x) (a) The Company has not issued any of its securities (including debt instruments) during the year and hence reporting under clause (x)(a) of the Order is not applicable. (b) During the year the Company has not made any preferential allotment or private placement of shares or convertible debentures (fully or partly or optionally) and hence reporting under clause (x)(b) of the Order is not applicable to the Company. (xi) (a) To the best of our knowledge, no fraud by the Company and no material fraud on the Company has been noticed or reported during the year. (b) To the best of our knowledge, no report under sub- section (12) of section 143 of the Companies Act has been filed in Form ADT-4 as prescribed under rule 13 of Companies (Audit and Auditors) Rules, 2014 with the Central Government, during the year and upto the date of this report. (c) We have taken into consideration the whistle blower complaints received by the Company during the year and upto the date of this report and provided to us, when performing our audit. (xii) The Company is not a Nidhi Company and hence reporting under clause (xii) of the Order is not applicable. (xiii) In our opinion, the Company is in compliance with Section 177 and 188 of the Companies Act, where applicable, for all transactions with the related parties and the details of related party transactions have been disclosed in the financial statements etc. as required by the applicable accounting standards. Annexure “B” To The Independent Auditor’s Report